All News

A long-term brain cancer survivor shares the story of his cancer journey and where it led his life.

From Georgia Congressman John Lewis receiving a tribute from the American Cancer Society to Sheryl Crow urging people to resume regular health and wellness screenings, here’s what’s happening in the cancer landscape this week.

In honor of Brain Cancer Awareness Month, CURE® spoke with an expert about the latest advances that researchers are working on for patients with this disease.

All patients with multiple myeloma have had MGUS, so what is it?

Patients with a history of cancer may become empowered to make diet and exercise changes by attending a clinic either virtually or in-person, which may also have a long-term impact on future risk for disease and outcomes.

A cancer survivor explains how she prevents an overwhelming and exhausting amount of doctor appointments from spoiling her appreciation for life.

In this episode of the “CURE® Talks Cancer” podcast, Maria Ciesla, an ovarian cancer survivor, and her daughter Alex Cornwell discuss Ciesla’s cancer journey and how it led them to do genetic testing that revealed they were both carriers of the BRCA1 mutation.

A roundup of some of CURE®’s latest news and updates for patients with bladder cancer in honor of Bladder Cancer Awareness Month this May.

According to a survey of 26 patients with advanced cancer, many reported that the U.S. opioid epidemic impacted their opinions of opioid use for pain management and conversations with their clinician regarding prescriptions.

A man who lost his wife to melanoma explains how he channeled his grief into advocacy that led to a change in legislation.

Participants who ate 18 grams of mushrooms a day had a 45% lower risk of developing cancer compared to those who do not eat them.

An analysis of more than 3.5 million children born between January 1996 and December 2016 demonstrated a stronger association between Down syndrome and acute myeloid leukemia risk than has been previously reported.

The Geron Corporation announced that the first patient has been dosed with GRN163L — an experimental agent — in a phase 3 clinical trial to assess the drug’s overall survival benefit compared to best available therapy in patients with refractory myelofibrosis.

Treatment with a novel therapy as a single agent, or in combination with Venclexta, demonstrated a manageable safety profile and antileukemic effects in patients with relapsed/refractory acute myeloid leukemia. The study authors, however, note that more research is needed.

A woman with metastatic breast cancer describes the overwhelming dread she feels every time she must wait to hear the results of a tumor marker test.

Prior to the program, patients with hematologic cancers walked an average of 136 steps in a 24-hour period. One month after the program began, that total increased to an average of 1,018 steps per day.

Treatment with daily Jakafi and parsaclisib improved spleen volume reduction and symptom burden in patients with myelofibrosis who had previously failed to achieve significant response to single-agent Jakafi.

A gynecologic oncologist who has spent her career helping patients during their cancer journeys goes a step further to educate women on how to advocate for themselves and possibly prevent cancer before it occurs.

On social media, CURE® recently asked its readers with rare cancers what advice they would offer to fellow patients with a similar diagnosis. Here’s what they shared.

"Some experiences we have as cancer survivors may help inspire those reluctant to get or complete COVID-19 vaccinations to follow through. We are all role models for each other."

Twenty percent of patients with resectable hepatocellular carcinoma had a significant amount of cell death when receiving Libtayo before surgical intervention.

There is a difference between patient and oncologists regarding prognosis, and patients are lacking understanding of prognosis and interventions needed to help them make more informed treatment choices.

A mother and caregiver describes how she views each moment with her daughter differently after her daughter’s breast cancer diagnosis.

Sophisticated analyses can predict which gut microbiome profile may lead to better outcomes to immunotherapy for patients with advanced melanoma.

Cancer survivors have the responsibility of sharing their knowledge of living in the world of cancer with the newly diagnosed, writes one survivor. Here, she shares ways to offer help.

Today is World Ovarian Cancer Day, and in honor of this day that was created in 2013 to raise awareness about the disease, CURE® is rounding up the latest news and updates in this cancer space.

Interim results from a phase 2 study demonstrated that patients inoperable or advanced intrahepatic cholangiocarcoma and a FGFR2 gene mutation had a disease control rate of 79% when treated with derazantinib.

Luckily, obtaining a second opinion has become easier with advances in telehealth and other virtual technologies, which allow patients to share their medical records and test results with physicians and pathologists to potentially improve treatment plans.

A melanoma survivor pens a poem about his cancer journey, losing his wife to melanoma and how he lives his life after these experiences.

From a 114-year-old cancer survivor breaking records to an operating room nurse giving birth to a cancer survivor’s baby, here’s what’s happening in the cancer landscape this week.